Search results for "INFORMATICS"

showing 10 items of 2542 documents

Parallel and scalable short-read alignment on multi-core clusters using UPC++

2016

[Abstract]: The growth of next-generation sequencing (NGS) datasets poses a challenge to the alignment of reads to reference genomes in terms of alignment quality and execution speed. Some available aligners have been shown to obtain high quality mappings at the expense of long execution times. Finding fast yet accurate software solutions is of high importance to research, since availability and size of NGS datasets continue to increase. In this work we present an efficient parallelization approach for NGS short-read alignment on multi-core clusters. Our approach takes advantage of a distributed shared memory programming model based on the new UPC++ language. Experimental results using the …

Parallel computingInternetGenome HumanBioinformaticsPGASShort read alignmentlcsh:RComputational BiologyHigh-Throughput Nucleotide SequencingReproducibility of Resultslcsh:Medicine004 InformatikHumansProgramming Languageslcsh:QHigh performance computinglcsh:ScienceSequence AlignmentAlgorithms004 Data processingResearch Article
researchProduct

Parent of origin effects in attention/deficit hyperactivity disorder (ADHD): analysis of data from the international multicenter ADHD genetics (IMAGE…

2008

Contains fulltext : 71540.pdf (Publisher’s version ) (Closed access) There are conflicting reports suggesting that the parental origin of transmitted risk alleles may play a role in the etiology of attention deficit/hyperactivity disorder (ADHD). A recent report by Hawi and colleagues observed a generalized paternal over-transmission of alleles associated with ADHD. This was not replicated in more recent studies. Using data from a large multicenter study we examined the overall and gene-specific parent of origin effect in 554 independent SNPs across 47 genes. Transmission disequilibrium and explicit parent of origin test were performed using PLINK. Overall parent of origin effect was tested…

ParentsCandidate geneGenetics and epigenetic pathways of disease [NCMLS 6]2804 Cellular and Molecular NeuroscienceMedizinNeuroinformatics [DCN 3]Linkage Disequilibrium2738 Psychiatry and Mental Health0302 clinical medicineRisk FactorsPerception and Action [DCN 1]Genetics(clinical)Genetics (clinical)0303 health sciencesTPH210058 Department of Child and Adolescent PsychiatryPsychiatry and Mental healthData Interpretation StatisticalFunctional Neurogenomics [DCN 2]Clinical psychologyGenetic Markers2716 Genetics (clinical)Single-nucleotide polymorphism610 Medicine & healthMental health [NCEBP 9]Polymorphism Single NucleotideGenetic determinismGenomic disorders and inherited multi-system disorders [IGMD 3]Molecular epidemiology [NCEBP 1]03 medical and health sciencesCellular and Molecular NeuroscienceCognitive neurosciences [UMCN 3.2]Translational research [ONCOL 3]medicineAttention deficit hyperactivity disorderHumansFamilyGenetic Predisposition to Diseaseddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleAlleles030304 developmental biologyChi-Square DistributionEndocrinology and reproduction [UMCN 5.2]business.industrymedicine.diseaseGenetic defects of metabolism [UMCN 5.1]Multicenter studyAttention Deficit Disorder with HyperactivityEtiologybusiness030217 neurology & neurosurgeryAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
researchProduct

Implementation of the norwegian ‘Starting right’ child health service innovation: implementation adjustments, adoption, and acceptability

2021

Abstract Background An increased and/or stable proportion of the child and adolescent population reports symptoms of impaired health, and the symptoms can be identified early. Therefore, structured child- and parent-reported outcome measures need to be implemented in child and school health services for decision support and identification of children at risk. We aimed to (a) qualitatively examine adjustments of active implementation from the pilot implementation of the Norwegian ‘Starting Right’ health service innovation including an online child health assessment tool and practical routines, and (b) measure practitioners´ adoption and parental acceptability. Methods We used a mixed-methods…

Parentsmedicine.medical_specialtyEvidence-based practicePopulationChild Health ServicesNorwegianHealth informaticsCore conceptsHealth administration03 medical and health sciences0302 clinical medicineEvidence‐based practiceHealth service innovationSurveys and QuestionnairesMedicineHumans0501 psychology and cognitive sciences030212 general & internal medicineService innovationeducationChildSchool Health ServicesChild healthMedical educationeducation.field_of_studybusiness.industryNorwayHealth PolicyNursing researchPublic healthlcsh:Public aspects of medicine05 social sciencesPublic health nurseslcsh:RA1-1270School healthVDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850language.human_languageDecision supportVDP::Medisinske Fag: 700::Helsefag: 800ImplementationChild PreschoollanguageFemalebusiness050104 developmental & child psychologyResearch ArticleBMC Health Services Research
researchProduct

G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson's Disease?

2019

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and has plagued humans for more than 200 years. The etiology and detailed pathogenesis of PD is unclear, but is currently believed to be the result of the interaction between genetic and environmental factors. Studies have found that PD patients with the LRRK2:G2019S variation have the typical clinical manifestations of PD, which may be familial or sporadic, and have age-dependent pathogenic characteristics. Therefore, the LRRK2:G2019S variation may be an ideal model to study the interaction of multiple factors such as genetic, environmental and natural aging factors in PD in the future. This article reviewed the …

Parkinson's diseaseNatural agingDiseaseReviewBioinformatics050105 experimental psychologylcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicineG2019s mutationG2019S mutationmedicine0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological Psychiatrybusiness.industrydisease modelpathogenesis05 social sciencesLRRK2medicine.diseaseLRRK2nervous system diseasesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyMultiple factorsVariation (linguistics)NeurologyEtiologyParkinson’s diseasebusiness030217 neurology & neurosurgeryNeuroscienceFrontiers in human neuroscience
researchProduct

Genetic epidemiology of Parkinson's disease

2004

Parkinson's diseaseNeurologyPlant disease epidemiologyMolecular epidemiologyGenetic epidemiologybusiness.industryMedicineNeurology (clinical)businessBioinformaticsmedicine.diseaseRevue Neurologique
researchProduct

Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies

2010

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is mainly characterized by the selective and progressive loss of dopaminergic neurons, accompanied by locomotor defects. Although most PD cases are sporadic, several genes are associated with rare familial forms of the disease. Analyses of their function have provided important insights into the disease process, demonstrating that three types of cellular defects are mainly involved in the formation and/or progression of PD: abnormal protein aggregation, oxidative damage, and mitochondrial dysfunction. These studies have been mainly performed in PD models created in mice, fruit flies, and worms. Among them, Dro…

Parkinson's diseasebiologyved/biologyved/biology.organism_classification_rank.speciesDopaminergicNeuroscience (miscellaneous)Review ArticleDiseasebiology.organism_classificationmedicine.diseaseBioinformaticslcsh:RC346-429PathogenesisPsychiatry and Mental healthmedicineNeurology (clinical)Model organismDrosophilaGenelcsh:Neurology. Diseases of the nervous systemFunction (biology)Parkinson's Disease
researchProduct

A Diet for Dopaminergic Neurons?

2009

Parkinson’s disease (PD) is the second most common neurodegenerative disease, which unfortunately is still fatal. Since the discovery of dopamine (DA) neuronal cell loss within the substantia nigra in PD, the past decades have seen the understanding of the pathophysiological mechanisms underlying the degenerative process advance at a very impressive rate. Nevertheless, there is at present no cure for PD. Although there are no proven therapies for prevention, a large body of evidence from animal studies has highlighted the paramount role of dietary factors in counteracting DA degeneration. Consistently, associations between the risk of developing PD and the intake of nutrients, individual fo…

Parkinson's diseasebusiness.industryNeurodegenerationDopaminergicSubstantia nigraDiseaseBioinformaticsmedicine.diseaseNeuroprotectionDopaminemedicineAnimal studiesbusinessmedicine.drug
researchProduct

Is antioxidant therapy effective to treat alzheimer's disease?

2011

Alzheimer’s disease (AD) is a neurodegenerative process associated with oxidative stress. In the past, it was claimed that all neuronal lesions involved in the onset and progression of AD were related to oxidative stress. Today, we know that intracellular amyloid beta (Ab) could play a central role in the pathophysiology of the disease. Ab binds to heme groups in mitochondrial membranes causing electron transport chain impairment and loss of respiratory function. The experimental evidence of such oxidative stress leads to the basis for treatment of AD with antioxidants. Many clinical trials have been developed to clarify whether antioxidants are beneficial in AD treatment. However, the resu…

Pathologymedicine.medical_specialtyAntioxidantbiologyAmyloid betamedicine.medical_treatmentDiseasemedicine.disease_causeBioinformaticsPathophysiologychemistry.chemical_compoundchemistrybiology.proteinmedicineRespiratory functionHemeIntracellularOxidative stressFree Radicals and Antioxidants
researchProduct

Oral encapsulated vascular malformation: an undescribed presentation in the mouth

2016

Vascular lesions have been classified in two broad categories, hemangiomas and malformations. Encapsulated vascular lesions have not been reported in the oral cavity, but they were described in other sites, mainly in the orbit. Herein, we present a case of an oral encapsulated vascular lesion located in the right buccal mucosa of a 69-year-old male, including histological and immunohistochemical description and a literature review. Key words:Buccal mucosa, hemangioma, vascular malformation, oral cavity.

Pathologymedicine.medical_specialtyCase ReportOdontologíaBioinformaticsOral cavityBuccal mucosaHemangioma03 medical and health sciences0302 clinical medicinemedicineGeneral DentistryOral Medicine and Pathologybusiness.industryVascular malformation030206 dentistryVascular lesionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludeye diseasesstomatognathic diseasesRight buccal mucosamedicine.anatomical_structure030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASsense organsPresentation (obstetrics)businessOrbit (anatomy)
researchProduct

Animal models of non-alcoholic steatohepatitis: of mice and man.

2010

The epidemic occurrence of obesity has led to a rapid increase in the incidence of non-alcoholic fatty liver disease (NAFLD) in industrial countries. The disease spectrum includes hepatic steatosis, lobular inflammation with steatohepatitis (NASH) and varying degrees of liver fibrosis, which can progress to cirrhosis. Hepatocellular carcinoma can develop in patients with NASH, even in the absence of cirrhosis. The majority of patients with primary NASH exhibit risk factors that define the metabolic syndrome including insulin resistance and visceral obesity. However, only a minority of patients with NAFLD progress to end-stage liver disease and, so far, predictors to identify these patients …

Pathologymedicine.medical_specialtyCirrhosisDiseaseBioinformaticsLiver diseaseMiceMethionineGenetic predispositionMedicineAnimalsHumansbusiness.industryFatty liverGastroenterologyGeneral Medicinemedicine.diseaseDietary Fatsdigestive system diseasesCholine DeficiencyFatty LiverDisease Models AnimalLiverSteatosisMetabolic syndromeSteatohepatitisbusinessDigestive diseases (Basel, Switzerland)
researchProduct